Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin for hemorrhagic fever with renal syndrome
ChiCTR2000034218Phase 4Not yet recruiting
- Sponsor
- Department of Infectious Diseases, Tangdu Hospital
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ribavirin in hemorrhagic fever with renal syndrome (HFRS) (2 arms), sponsored by Department of Infectious Diseases, Tangdu Hospital. Primary endpoint: Serum hantavirus load. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
ribavirin
03
Conditions
hemorrhagic fever with renal syndrome (HFRS)
Beyond the preview
Go deeper on ChiCTR2000034218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034218.